Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
NIAID Awards Zepto Life Technology a $8.9 Million Contract for Liquid Biopsy Platform Development.
Aug 12, 2026•about 3 hours ago
Contract Type
contract
Description
Zepto Life Technology has secured a contract worth up to $8.9 million from NIAID to develop a plasma cell-free DNA diagnostic system aimed at identifying invasive fungal infections. This project includes engineering and conducting a multi-center clinical study to support FDA submission.
Agreement Insights
Based on industry dataContract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months